Unique ID issued by UMIN | UMIN000034210 |
---|---|
Receipt number | R000038998 |
Scientific Title | A Study on Symptoms, Impairment, and Treatment Status of COPD Patients in Japan: A Retrospective Analysis of an Existing Internet-Based Questionnaire (DREAM COPD study) |
Date of disclosure of the study information | 2018/09/20 |
Last modified on | 2020/10/28 12:23:57 |
A Study on Symptoms, Impairment, and Treatment Status of COPD Patients in Japan: A Retrospective Analysis of an Existing Internet-Based Questionnaire (DREAM COPD study)
A Study on Symptoms, Impairment, and Treatment Status of COPD Patients in Japan: A Retrospective Analysis of an Existing Internet-Based Questionnaire (DREAM COPD study)
A Study on Symptoms, Impairment, and Treatment Status of COPD Patients in Japan: A Retrospective Analysis of an Existing Internet-Based Questionnaire (DREAM COPD study)
A Study on Symptoms, Impairment, and Treatment Status of COPD Patients in Japan: A Retrospective Analysis of an Existing Internet-Based Questionnaire (DREAM COPD study)
Japan |
Chronic Obstructive Pulmonary Disease
Pneumology |
Others
NO
To clarify the situation of the influence(burden) in daily life in regard to the presence of COPD-related symptoms and the time of occurrence in the subjects of this study
Others
A retrospective analysis of internet-based questionnaire
Exploratory
Others
Not applicable
To clarify the presence of COPD-related symptoms and the time of occurrence in the subjects of this study.
Percentage of patients who responded that COPD-related symptoms are impairing with daily life are shown for each occurrence time zone.
For each treatment situation, describe the following items.
1)The presence of COPD-related symptoms.
2)The presence of burden in daily life.
3)Explanatory contents that the doctor provided to the patient at the time of diagnosis.
4)Presence of setting of treatment goal between physician and patient.
Others,meta-analysis etc
40 | years-old | <= |
Not applicable |
Male and Female
1)40 years old and over.
2)Those who have a diagnosis history of COPD, emphysema or chronic bronchitis.
3)Those who answered to all survey items.
Those who have a diagnosis history of asthma.
456
1st name | |
Middle name | |
Last name | Tatsunori Jinnai |
AstraZeneca K.K.
Evidence & Observational Reseach Medical
Grand Front Osaka Tower B 3-1, Ofuka-cho, Kita-ku, Osaka
06-7711-3714
Tatsunori.Jinnai@astrazeneca.com
1st name | |
Middle name | |
Last name | Shigetoshi Kageyama |
EP-CRSU Co.,Ltd
Clinical Research Headquarters
Acropolis TOKYO Bldg.,6-29 Shinogawamachi, Shinjuku-ku,Tokyo
03-6759-9904
kageyama862@eps.co.jp
AstraZeneca K.K.
AstraZeneca K.K.
Profit organization
NO
該当なし
2018 | Year | 09 | Month | 20 | Day |
https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000038998
Published
http://www.pieronline.jp/content/article/0289-5803/37060/77
456
The most frequent symptom was short breath/feeling of dyspnea at daytime (114 patients, 45%), and it occurred the any time of the day. There were 101 patients with impairment due to symptoms at any time of a day, the most common symptom is short breath/feeling of dyspnea at daytime. Of the 250 patients with COPD-related symptom, 114 patients (58%) were treated with some medication. patients who had proposal of therapeutic target were more likely to receive medication.
2020 | Year | 10 | Month | 28 | Day |
Male 313(96.9%), Female 10(3.1%)
not applicable
not applicable
Of the 323 patients with a history of emphysema or COPD, 250 patients (77%) were aware of some kinds of symptom.
In comparison by each time zone, the most frequent symptom was short breath/feeling of dyspnea at daytime (114 patients, 45%), and it occurred the any time of the day, including evening to bedtime.
There were 101 patients (40% of patients who were aware of symptom) with impairment due to symptoms at any time of a day, the most common symptom is short breath/feeling of dyspnea at daytime (72 patients,50%), in comparison with other times within a day.
Of the 250 patients with COPD-related symptom, 114 patients (58%) were treated with some medication. patients who had proposal of therapeutic target were more likely to receive medication.
In conclusion, the task is that the diffusion of appropriate COPD treatment in consideration of the type of symptom and the occurrence time of symptom and impairment. Appropriate communication between doctors and patients such as proposing therapeutic target at the beginning of treatment was considered important.
Completed
2018 | Year | 09 | Month | 07 | Day |
2018 | Year | 09 | Month | 20 | Day |
2018 | Year | 09 | Month | 20 | Day |
2018 | Year | 09 | Month | 20 | Day |
2018 | Year | 11 | Month | 07 | Day |
2019 | Year | 03 | Month | 06 | Day |
A retrospective analysis of an existing internet-based questionnaire
2018 | Year | 09 | Month | 20 | Day |
2020 | Year | 10 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038998
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |